Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency

Journal: Journal of Clinical Investigation

Published: 2018-07-02

DOI: 10.1172/jci98164

Affiliations: 23

Authors: 34

Go to article
Institutions FC
NIH Department of Laboratory Medicine, United States of America (USA) 0.18
Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Imagine Institute, France 0.12
Department of Pediatrics and Developmental Biology, TMDU, Japan 0.06
NIH NIAID Laboratory of Clinical Infectious Diseases (LCID), United States of America (USA) 0.06
Duke Department of Pediatrics, United States of America (USA) 0.06
Department of Pediatrics, MCW, United States of America (USA) 0.06
Institut Necker Enfants Malades (INEM), France 0.06
Hospital Timone, France 0.06
UC Division of Human Genetics, United States of America (USA) 0.04
UC Division of Bone Marrow Transplantation and Immune Deficiency, United States of America (USA) 0.04
Department of Pediatrics, Nagoya University, Japan 0.03
Japanese Red Cross Nagoya First Hospital, Japan 0.03
Dr. von Hauner Children's Hospital, LMU, Germany 0.03
Centre d’Immunologie de Marseille-Luminy (CIML), France 0.03
Atrium Health, United States of America (USA) 0.03
Institute of Mineralogy, Materials Physics and Cosmochemistry (IMPMC), France 0.03
School of Medicine (SOM), SC, United States of America (USA) 0.03
Imagine Institute, France 0.02
Centre d’Etude des Déficits Immunitaires (CEDI), Hôpital Necker-Enfants Malades, France 0.01
Immunologie - Hématologie et Rhumatologie Pédiatrique, Hôpital Necker-Enfants Malades, France 0.01
Collège de France, France 0.01

Return